The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function (Q33595360)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function (English)

1 reference

Europe PubMed Central

28 July 2017

1 reference

based on heuristic

inferred from title

experimental autoimmune encephalomyelitis

1 reference

based on heuristic

inferred from title

author name string

Jia Ni

1

1 reference

Europe PubMed Central

28 July 2017

Yi-Na Zhu

2

1 reference

Europe PubMed Central

28 July 2017

Xiang-Gen Zhong

3

1 reference

Europe PubMed Central

28 July 2017

Yu Ding

4

1 reference

Europe PubMed Central

28 July 2017

Li-Fei Hou

5

1 reference

Europe PubMed Central

28 July 2017

Xian-Kun Tong

6

1 reference

Europe PubMed Central

28 July 2017

Wei Tang

7

1 reference

Europe PubMed Central

28 July 2017

Shiro Ono

8

1 reference

Europe PubMed Central

28 July 2017

Yi-Fu Yang

9

1 reference

Europe PubMed Central

28 July 2017

Jian-Ping Zuo

10

1 reference

Europe PubMed Central

28 July 2017

language of work or name

0 references

publication date

1 December 2009

1 reference

Europe PubMed Central

28 July 2017

British Journal of Pharmacology

1 reference

Europe PubMed Central

28 July 2017

158

1 reference

Europe PubMed Central

28 July 2017

8

1 reference

Europe PubMed Central

28 July 2017

2046-2056

1 reference

Europe PubMed Central

28 July 2017

The attraction of chemokines as a target for specific anti-inflammatory therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807666

21 June 2018

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807666

21 June 2018

A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807666

21 June 2018

Chemokines and chemokine receptors: potential therapeutic targets in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807666

21 June 2018

The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807666

21 June 2018

The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807666

21 June 2018

Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807666

21 June 2018

Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807666

21 June 2018

Chemokines in autoimmune diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807666

21 June 2018

CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807666

21 June 2018

The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807666

21 June 2018

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807666

21 June 2018

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807666

21 June 2018

Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807666

21 June 2018

Guide to Receptors and Channels (GRAC), 3rd edition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00528.X

21 January 2018

CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00528.X

21 January 2018

Chemical genetics: where genetics and pharmacology meet

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00528.X

21 January 2018

Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00528.X

21 January 2018

Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00528.X

21 January 2018

CXCR3 Signaling Reduces the Severity of Experimental Autoimmune Encephalomyelitis by Controlling the Parenchymal Distribution of Effector and Regulatory T Cells in the Central Nervous System

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00528.X

21 January 2018

Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807666

30 October 2018

Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807666

30 October 2018

Chemokine expression in murine experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00528.X

21 January 2018

Immunology of multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20050195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20050195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

COX-2 inhibitors ameliorate experimental autoimmune encephalomyelitis through modulating IFN-gamma and IL-10 production by inhibiting T-bet expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/20050195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20050195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/20050195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A critical role for IL-12 in CCR5 induction on T cell receptor-triggered mouse CD4(+) and CD8(+) T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20050195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of the chemokine receptor CXCR3 on TCR-stimulated T cells: dependence on the release from persistent TCR-triggering and requirement for IFN-gamma stimulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20050195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A non-peptide CCR5 antagonist inhibits collagen-induced arthritis by modulating T cell migration without affecting anti-collagen T cell responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/20050195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-12 dependent/IFN gamma independent expression of CCR5 by myelin-reactive T cells correlates with encephalitogenicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20050195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop

1 reference

https://pubmed.ncbi.nlm.nih.gov/20050195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20050195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20050195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20050195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20050195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of cell types producing RANTES, MIP-1 alpha and MIP-1 beta in rat experimental autoimmune encephalomyelitis by in situ hybridization

1 reference

https://pubmed.ncbi.nlm.nih.gov/20050195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1alpha and monocyte chemotactic protein-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/20050195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20050195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1476-5381.2009.00528.X

1 reference

Europe PubMed Central

28 July 2017

release_srbeibjy5fagthlg35hdgavh2q

1 reference

https://api.fatcat.wiki/v0/release/srbeibjy5fagthlg35hdgavh2q

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33595360&oldid=1968907206"